Covidien Changes Optimark Label To Include Renal Risk - Update - RTT News PDF Print
RTT NewsThe FDA recommended the avoidance of GBCAs in patients with severe renal impairment, in 2007. "In addition, the FDA will hold a joint Advisory Committees

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.